Back to search
FDAFDA · Food and drugs·Recall number D-0874-2016

ORIS (chlorhexidine gluconate), oral rinse, 0.12%, packaged in 16 fl. oz. (473 mL) PET bottle, Rx only, Manufactured for DENTSPLY Professional, York, PA 17404, UPC D00513003001O

Published June 1, 2016 · Recall initiated: March 23, 2016

Summary

FDA records drug Class II recall D-0874-2016, published June 1, 2016 and initiated March 23, 2016. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 33,862 mL; Lot: Lot # 628146, Exp 6/16; 629690, Exp 9/16; 348295, Exp 10/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot # 628146, Exp 6/16; 629690, Exp 9/16; 348295, Exp 10/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ORIS (chlorhexidine gluconate), oral rinse, 0.12%, packaged in 16 fl. oz. (473 mL) PET bottle, Rx only, Manufactured for DENTSPLY Professional, York, PA 17404, UPC D00513003001O recalled?

Yes. FDA published recall D-0874-2016 on June 1, 2016. Reported hazard: Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.

What should I do if I have this product?

Voluntary: Firm initiated · Letter